Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Perry Olshan"'
Autor:
Charles J. Schneider, Michael Krainock, Allyson Koyen Malashevich, Meenakshi Malhotra, Perry Olshan, Paul R. Billings, Alexey Aleshin
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 849-853 (2021)
Immunotherapy (IO) has increasingly been demonstrated to provide therapeutic benefit to patients with metastatic colorectal cancer (mCRC). However, only a subset of mCRC tumors respond to IO. Monitoring response with tumor biomarkers like carcinoembr
Externí odkaz:
https://doaj.org/article/718109250eb1486fa0b03794c8bc919a
Autor:
Meenakshi Malhotra, Alexey Aleshin, Pashtoon Murtaza Kasi, Allyson Koyen Malashevich, Griffin Budde, Michael Krainock, Vasily N Aushev, Perry Olshan, Paul R Billings
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/313a4178cc364854b38439068ed47929
Autor:
Stacey A. Cohen, Anup Kasi, Nicole Hook, Michael Krainock, Griffin Budde, Allyson Koyen Malashevich, Jeffrey Meltzer, Russ Jelsema, Perry Olshan, Paul R. Billings, Alexey Aleshin, Andrew S. Poklepovic
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2022 (2022)
The number of pregnant women with cancer is on the rise. These patients and their providers encounter complex medical management decisions. Standard-of-care systemic therapy and radiological imaging can impair fetal development and affect viability.
Externí odkaz:
https://doaj.org/article/d159d32c0baa423397d54d72db0ae461
Autor:
Zeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, Sumedha Sudhaman, Turkan Ozturk Topcu, Matt Nichols, Justin Martin, Katherine M. Bui, Charuta C. Palsuledesai, Meenakshi Malhotra, Perry Olshan, Joseph Markowitz, Nikhil I. Khushalani, Ahmad A. Tarhini, Jane L. Messina, Alexey Aleshin
Publikováno v:
Cancer. 129:1723-1734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27be02bd9a5b58baccb072c7e38537dc
https://doi.org/10.1002/cncr.34716
https://doi.org/10.1002/cncr.34716
Autor:
Soo J. Park, Aarthi Kannan, Jeremy P. Harris, Curtis Lacy, Gregory A. Daniels, Steve P. Lee, Nils Lambrecht, Nicole Hook, Perry Olshan, Paul R. Billings, Alexey Aleshin, Ling Gao
Publikováno v:
Journal of the American Academy of Dermatology. 87:1209-1211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37de4e587e82acbd87401b51e3c2865
https://doi.org/10.1016/j.jaad.2022.03.020
https://doi.org/10.1016/j.jaad.2022.03.020
Autor:
Meenakshi Malhotra, Michael Krainock, Alexey Aleshin, Paul Billings, Perry Olshan, Charles Schneider, Allyson Koyen Malashevich
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 14, Iss 2, Pp 849-853 (2021)
Case Reports in Oncology, Vol 14, Iss 2, Pp 849-853 (2021)
Immunotherapy (IO) has increasingly been demonstrated to provide therapeutic benefit to patients with metastatic colorectal cancer (mCRC). However, only a subset of mCRC tumors respond to IO. Monitoring response with tumor biomarkers like carcinoembr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf30672fa4feca58857ddb70ed193619
https://doi.org/10.1159/000516190
https://doi.org/10.1159/000516190
Autor:
Nicole Hook, Perry Olshan, Urmeel Patel, Angel Rodriguez, Meenakshi Malhotra, Alexey Aleshin, Paul Billings
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:CLO21-024
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1233680fed15fe1e4fbb6a321b122a0f
https://doi.org/10.6004/jnccn.2020.7736
https://doi.org/10.6004/jnccn.2020.7736
Autor:
Pashtoon Murtaza Kasi, Griffin Budde, Michael Krainock, Vasily N Aushev, Allyson Koyen Malashevich, Meenakshi Malhotra, Perry Olshan, Paul R Billings, Alexey Aleshin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Immune checkpoint inhibitors have shown great promise in treating patients with mismatch repair deficient/microsatellite instability high (dMMR/MSI-H) colorectal cancer (CRC). Although single-agent pembrolizumab has been approved for first-line treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cc2a8945f3bfcc3fe1efa9cda71fee
https://jitc.bmj.com/content/10/1/e003312.full
https://jitc.bmj.com/content/10/1/e003312.full
Autor:
Meenakshi Malhotra, Alexey Aleshin, Jiaqiong Xu, Ekaterina V. Kalashnikova, Shruti Sharma, Abdullah Esmail, Maen Abdelrahim, Tiffany A Katz, Paul Billings, Perry Olshan
Publikováno v:
Journal of Surgery and Research.
Pancreatic ductal adenocarcinoma (PDAC) has one of the most aggressive cancer histologies, with high recurrence (85%) and a 5-year survival rate of 9%. The circulating tumor DNA (ctDNA) is evolving field in setting of management for patients with adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bddb199f1a2c9d67c1b96f19e3d5246
https://doi.org/10.26502/jsr.10020173
https://doi.org/10.26502/jsr.10020173
Autor:
Georges Azzi, Mehrad Tavallai, Gregory P. Botta, Mohamedtaki Abdulaziz Tejani, Diana L. Hanna, Adham Adel Jurdi, Griffin Budde, Shifra Krinshpun, Minu Maninder, Vasily N. Aushev, Perry Olshan, Paul R. Billings, Alexey Aleshin, Pashtoon Murtaza Kasi
Publikováno v:
Journal of Clinical Oncology. 40:6-6
6 Background: For patients with anal squamous cell carcinoma (ASCC), the current standard of care involves curative-intent definitive chemoradiation. For those that recur locally, salvage surgery maybe a consideration. ASCC, however, still lacks a no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e887a3be309773733ab471ab9fbbdcb7
https://doi.org/10.1200/jco.2022.40.4_suppl.006
https://doi.org/10.1200/jco.2022.40.4_suppl.006